BioJet

BioJet is a Russian pharmaceutical manufacturing company focused on full-cycle production of modern biotechnological medicines. The company was established in 2021 and operates as part of the PharmEco group, with its manufacturing site located in the Technopolis Moscow special economic zone. BioJet positions itself as a producer of biotech drugs and has highlighted plans related to import-substitution manufacturing in Russia, including targeted oncology products and potential biosimilar production. Its facility is equipped for sterile solution and lyophilized vial manufacturing, and the company obtained a pharmaceutical manufacturing license in November 2025. Overall, BioJet appears to be a manufacturing-led biotech/pharma company rather than a discovery-stage therapeutic developer.